Skip to content

PUBLIPHARMA

Active
Private limited company (pre-2019)founded 200521 yrs activeKBO/BCE: BE 0873.735.121
Summary

The computed 12-month bankruptcy probability of PUBLIPHARMA is 9.0% (elevated). The 2019 annual accounts show negative equity (-€110,377). The company has been active since 2005 and the Belgian State Gazette contains no insolvency signals. The CBE does carry 2 administrative register entries (see administrative flags).

Checked score

No current score
Figures too old
The available figures for FY 2019 are too old to assess current financial health.
Bankruptcy probability: Elevated
Filing: Five or more filing cycles are missing. This points to a standstill, not an imminent failure.
Axes, FY 2019
Profitability-
Solvency0
Growth-
Track record69
Bankruptcy probability, 12 months
9.0% Elevated
0%0.5%1.5%4%10%≥ 25%
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2019
Age of the figures
Age of the figures
90 mo
raises risk · Recent warning signals
The last 24 months brought warning signals in the Staatsblad or the KBO, and those often pile up before a bankruptcy.
Belgian State Gazette
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 21 years 0 30 y
raises risk · Ex-officio strike-off
The KBO struck this company off ex officio, which points to unmet obligations and often precedes a bankruptcy.
KBO publications
neutral · No filing for years
The last filed financial year closed on 31-03-2019. Since then, 6 financial years are missing. This points to a standstill, not an imminent failure.
NBB · 10 filings
Position against the passed deadline
31-03-2020 close31-10-2020 deadline28-09-2026 today
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2019 was due by 31-10-2019 and was filed on 30-10-2019, 1 day ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
not filed
2024
not filed
2023
not filed
2022
not filed
2021
not filed
2020
not filed
2019
1 d early
← before the deadline after the deadline →
tick = median of all Belgian filings

This company filed its 2019 accounts 1 day before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

raises risk · Administrative warnings in the KBO publications
2 publications by the FPS Economy about this company, such as a strike-off for address, accounts or UBO, or their withdrawal.
KBO publications
Publications
Late accounts filingAddress struck

History

PUBLIPHARMA was incorporated on 11 May 2005.1 The company has filed 10 sets of annual accounts, the latest for fiscal year 2019.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2019

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2019, micro schema

Equity
-€110,377
Total assets
€8,326
Net result
Not included in this filing
Working capital
-€110,377

Turnover and EBIT margin not published: the micro schema does not require them.

Key figures and ratios
2019 value
Current ratio
0.07
Debt
€118,704
Debt ≤ 1 year
€118,704
A ratio outside any meaningful range has been withheld (balance sheet total €8,326, equity -€110,377).
Annual accounts
Filed annual accounts As filed with the NBB · 2019 · 10 lines
Balance sheet Code2019
Assets
Total assets20/58€8,326
Current assets29/58€8,326
Amounts receivable within one year40/41€1,112
Cash at bank and in hand54/58€7,215
Equity and liabilities
Total equity and liabilities10/49€8,326
Equity10/15-€110,377
Contributions10/11€18,600
Profit (loss) carried forward14-€128,977
Amounts payable17/49€118,704
Amounts payable within one year42/48€118,704

Not filed in this scheme.

Line2019
Assets
Total assets20/58€8,326
Current assets29/58€8,326
Amounts receivable within one year40/41€1,112
Cash at bank and in hand54/58€7,215
Equity and liabilities
Total equity and liabilities10/49€8,326
Equity10/15-€110,377
Contributions10/11€18,600
Profit (loss) carried forward14-€128,977
Amounts payable17/49€118,704
Amounts payable within one year42/48€118,704

Not filed in this scheme.

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2026
28-04
KBO administration Address struck
event 12-04-2026
2024
01-03
KBO administration Late accounts filing
event 19-02-2024
2019
30-10
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
30-10
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 364 days late
2018
04-01
NBB filing Annual accounts filed
fiscal year 2017 · micro schema · 65 days late
2016
07-12
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema · 37 days late
2012
27-11
NBB filing Annual accounts filed
fiscal year 2012 · abbreviated schema · 27 days late
2011
16-12
NBB filing Annual accounts filed
fiscal year 2011 · abbreviated schema · 46 days late
31-01
NBB filing Annual accounts filed
fiscal year 2010 · abbreviated schema · 92 days late
2009
27-10
NBB filing Annual accounts filed
fiscal year 2009 · abbreviated schema
2008
16-12
NBB filing Annual accounts filed
fiscal year 2008 · abbreviated schema · 46 days late
2007
19-10
NBB filing Annual accounts filed
fiscal year 2007 · abbreviated schema
SignalNBB filing

Directors · office · real estate

Directors
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
Location & real-estate footprint
Registered office, Oostende · 1 establishment unit since 2005
seat establishment The establishment unit on the map
Ground area
570 m²
Building footprint
315 m²
Volume, LiDAR
4,056 m³
2 parcels, Flanders · tallest building 20.7 m, ±6 floors. Linked by address, not a title deed.
5 companies at this address See who is registered here
1 establishment unit
-
de Limburg Stirumstraat 24, 8370 BlankenbergeNACE 51180
since 20052.147.507.348
2 parcels
Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
31004A0793/00N020 Flanders 404 m² 1 · 125 m² 14.8 m · 3 fl.
35013A1186/00K000 Flanders 166 m² 1 · 190 m² 20.7 m · 6 fl.
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Identification & contact

Identification
Legal formPrivate limited company (pre-2019)
Founded11-05-2005
Fiscal year end31-03
E-invoicing
Not found in the Peppol register

No Peppol card under this enterprise or VAT number. That proves nothing: publishing a card is voluntary.

What can you do?

Try sending from your invoicing software; if that fails, ask the customer whether they already receive via Peppol.

If the customer is not ready yet, you may send the invoice another way, for example as a PDF; if electronically, with their agreement on a secure alternative. That invoice is valid; the customer risks a penalty. FPS Finance

Register as of 28 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.